Atomwise

About

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco,California,United States
101 - 250
http://www.atomwise.com

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $123M
Industries: Artificial Intelligence,Biotechnology,Health Care,Machine Learning,Medical,Pharmaceutical
Founded date: Jan 1, 2012
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Atomwise, Inc.

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
Learn more at atomwise.com, or connect on Twitter and LinkedIn.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$176.64M

Atomwise has raised a total of $176.64M in funding over 2 rounds. Their latest funding was raised on Oct 6, 2020 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 6, 2020	Grant	$2.30M	1	Bill & Melinda Gates Foundation	—	Detail
Aug 11, 2020	Series B	$123M	10	B Capital Group Sanabil	—	Detail
Mar 7, 2018	Series A	$45M	9	Monsanto Growth Ventures (MGV)	—	Detail
Aug 14, 2017	Series A	—	—	—	—	Detail
Jun 3, 2015	Seed	$6M	8	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

22

Atomwise is funded by 22 investors. Bill & Melinda Gates Foundation and B Capital Group are the most recent investors.

Investor Name	Lead Investor	Funding Round
Bill & Melinda Gates Foundation	Yes	Grant
B Capital Group	Yes	Series B
Sanabil	Yes	Series B
Monsanto Growth Ventures (MGV)	Yes	Series A
AME Cloud Ventures	—	Series B
Baidu Ventures	—	Series B
Colorcon	—	Series B
DCVC	—	Series B
Dolby Family Ventures	—	Series B
Tencent	—	Series B